13 - 15 November, 2018 | Hilton London Kensington, London, United Kingdom

Arjan Roozen


CTO and Head of Manufacturing
Zelluna Immunotherapy


4:30 PM Case Study: Ensuring Viable and Precise Production of Autologous TCR-T Cells

  • Discuss the challenges of scaling Autologous Cell Production with reference to viability and precision of treatment
  • Analyse specialised manufacturing techniques to enhance natural production
  • Cost vs Gain: looking at the reality of implementing new technology when demand is hard to forecast


Check out the incredible speaker line-up to see who will be joining Arjan.

Download The Latest Agenda